Johnson & Johnson Named Strategic Enterprise by Hong Kong's OASES

Johnson & Johnson has been designated as a Strategic Enterprise by Hong Kong's Office for Attracting Strategic Enterprises (OASES), reinforcing its commitment to the region. The collaboration aims to enhance health and medical innovation, bolster clinical research, and develop healthcare talent in Hong Kong. Johnson & Johnson will partner with government, healthcare institutions, and academic entities to improve patient access to healthcare innovations, supporting Hong Kong's goal of becoming a leading hub for health and medical innovation.